Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Nanchang UniversityActive in the last 2 years

Xiaozhong Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8152-8971; OpenAlex author ID A5100620371. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 7

  1. Construction of a prognostic model based on the cuproptosis-related genes in pancreatic cancer. Last author DOI 10.1016/j.gendis.2024.101391↗
  2. Utilization of cuproptosis-related lncRNAs to predict the prognosis of pancreatic cancer patients and explore their roles in immune cell infiltration and progn… Last author DOI 10.1016/j.gendis.2024.101409↗
  3. A prognostic model of patients with pancreatic cancer based on four N6-methyladenosine-related lncRNAs and analysis of related immune infiltration. Last author DOI 10.1016/j.gendis.2023.101141↗
  4. Seven Glycolysis-Related Genes Predict the Prognosis of Patients With Pancreatic Cancer. Last author DOI 10.3389/fcell.2021.647106↗
  5. Corrigendum: Seven Glycolysis-Related Genes Predict the Prognosis of Patients With Pancreatic Cancer. Last author DOI 10.3389/fcell.2021.695280↗
  6. Combining bioinformatics techniques to explore the molecular mechanisms involved in pancreatic cancer metastasis and prognosis. Last author DOI 10.1111/jcmm.16023↗
  7. Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p. Co-author DOI 10.1016/j.bbrc.2016.11.120↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kaili Liao · 6 shared papers, 2020–2025 · strength 1.09
  2. Jiasheng Xu · 2 shared papers, 2021 · strength 0.32
  3. Han Nie · 2 shared papers, 2021 · strength 0.32
  4. Jia‐Sheng Xu · 1 shared paper, 2020 · strength 0.15
  5. Yeqing Zou · 1 shared paper, 2017 · strength 0.07
  6. Bo Huang · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.